NFKB1 and obesity disorder: It has been established that anthocyanins inhibit NF‐κB activation, which prevents the transcription of these inflammatory cytokines and reduces universal inflammation (Santamarina et al. 2023) in obesity and metabolic disorders, where chronic inflammation within the adipose tissue intensifies insulin resistance.